Phosphorylcholine Polymer Conjugation Improves the Pharmaceutical Performance of Protein Therapeutics
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c00253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Jie Ren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, California 90095, United States. Hauptthemen laut MEDLINE: Phosphorylcholine, Polymers, Polymethacrylic Acids, Methacrylates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Cancer Center, University of Kansas, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, California 90095, United States.
- Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047, United States.
ORCID-Profile: Amin Haghighat Naeini, Nishant Kumar, Ming Zhao
Förderung
- Cancer Center, University of Kansas
- National Institute of General Medical Sciences
Zitieren
APA
Ren, J., Haghighat Naeini, A., Kumar, N., & Zhao, M. (2025). Phosphorylcholine Polymer Conjugation Improves the Pharmaceutical Performance of Protein Therapeutics. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00253
Vancouver
Ren J, Haghighat Naeini A, Kumar N, Zhao M. Phosphorylcholine Polymer Conjugation Improves the Pharmaceutical Performance of Protein Therapeutics. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00253
BibTeX
@article{Ren2025,
author = {Ren, Jie and Haghighat Naeini, Amin and Kumar, Nishant and Zhao, Ming},
title = {Phosphorylcholine Polymer Conjugation Improves the Pharmaceutical Performance of Protein Therapeutics},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c00253}
}
EUVIMED